Peter Wrighton-Smith Insider Trading $OXFD Oxford Immunotec Global PLC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Peter Wrighton-Smith.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter Wrighton-Smith. Peter Wrighton-Smith is Chief Executive Officer in Oxford Immunotec Global PLC ($OXFD).
Peter Wrighton-Smith in Oxford Immunotec Global PLC
Trading Symbol: OXFDIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Peter Wrighton-Smith: Chief Executive Officer
Holdings: 358,700 shares
Current Value: $4,788,645
Latest Transaction: May 12 2020
$OXFD Market Capitalization: $304.67M
$OXFD Previous Close: $13.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Peter Wrighton-Smith in Oxford Immunotec Global PLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 12 2020 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | P | 11.56 | 15,525 | 179,469 | 400,225 | 384.7 K to 400.2 K (+4.04 %) |
May 12 2020 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | P | 11.45 | 26,000 | 297,700 | 384,700 | 358.7 K to 384.7 K (+7.25 %) |
May 12 2020 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | P | 10.75 | 2,075 | 22,306 | 358,700 | 356.6 K to 358.7 K (+0.58 %) |
Oct 03 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.21 | 30,000 | 486,402 | 294,538 | 324.5 K to 294.5 K (-9.24 %) |
Sep 25 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 17.01 | 80,000 | 1,361,096 | 324,538 | 404.5 K to 324.5 K (-19.78 %) |
Sep 25 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 14.92 | 20,000 | 298,366 | 404,538 | 424.5 K to 404.5 K (-4.71 %) |
Aug 20 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 13.86 | 10,000 | 138,647 | 424,538 | 434.5 K to 424.5 K (-2.30 %) |
Apr 03 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | A | 16.42 | 67,959 | 1,115,887 | 67,959 | |
Apr 03 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 17.21 | 600 | 10,326 | 434,538 | 435.1 K to 434.5 K (-0.14 %) |
Apr 03 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.64 | 10,000 | 166,446 | 435,138 | 445.1 K to 435.1 K (-2.25 %) |
Apr 03 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Grant | A | 0.00 | 31,669 | 0 | 445,138 | 413.5 K to 445.1 K (+7.66 %) |
Feb 20 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.99 | 10,000 | 169,934 | 413,469 | 423.5 K to 413.5 K (-2.36 %) |
Jan 11 2019 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 14.91 | 10,000 | 149,073 | 423,469 | 433.5 K to 423.5 K (-2.31 %) |
Oct 03 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.93 | 10,000 | 169,260 | 433,469 | 443.5 K to 433.5 K (-2.25 %) |
Oct 03 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.50 | 10,000 | 165,000 | 443,469 | 453.5 K to 443.5 K (-2.21 %) |
Sep 27 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 54,273 | 43,961 | 0 | |
Sep 27 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 18.92 | 46,100 | 872,064 | 453,469 | 499.6 K to 453.5 K (-9.23 %) |
Sep 27 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 17.84 | 40,000 | 713,704 | 499,569 | 539.6 K to 499.6 K (-7.41 %) |
Sep 27 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 54,273 | 43,961 | 539,569 | 485.3 K to 539.6 K (+11.18 %) |
Sep 10 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 40,000 | 32,400 | 54,273 | |
Sep 10 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 14.95 | 40,000 | 598,000 | 485,296 | 525.3 K to 485.3 K (-7.61 %) |
Sep 10 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 40,000 | 32,400 | 525,296 | 485.3 K to 525.3 K (+8.24 %) |
Mar 19 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | A | 13.24 | 103,330 | 1,368,089 | 103,330 | |
Mar 19 2018 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Grant | A | 0.00 | 23,628 | 0 | 485,296 | 461.7 K to 485.3 K (+5.12 %) |
Oct 04 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 55,000 | 44,550 | 94,273 | |
Oct 04 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.78 | 55,000 | 922,933 | 461,668 | 516.7 K to 461.7 K (-10.65 %) |
Oct 04 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 55,000 | 44,550 | 516,668 | 461.7 K to 516.7 K (+11.91 %) |
Jul 10 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 27,168 | 22,006 | 149,273 | |
Jul 10 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 15.94 | 27,168 | 433,006 | 461,668 | 488.8 K to 461.7 K (-5.56 %) |
Jul 10 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 27,168 | 22,006 | 488,836 | 461.7 K to 488.8 K (+5.88 %) |
Jul 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 16,394 | 13,279 | 176,441 | |
Jul 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 16,438 | 13,315 | 0 | |
Jul 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.58 | 16,394 | 271,849 | 461,668 | 478.1 K to 461.7 K (-3.43 %) |
Jul 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 16,394 | 13,279 | 478,062 | 461.7 K to 478.1 K (+3.55 %) |
Jul 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.58 | 16,438 | 272,578 | 461,668 | 478.1 K to 461.7 K (-3.44 %) |
Jul 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 16,438 | 13,315 | 478,106 | 461.7 K to 478.1 K (+3.56 %) |
Jun 29 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 30,000 | 24,300 | 16,438 | |
Jun 29 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 16.06 | 30,000 | 481,797 | 461,668 | 491.7 K to 461.7 K (-6.10 %) |
Jun 29 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 30,000 | 24,300 | 491,668 | 461.7 K to 491.7 K (+6.50 %) |
Apr 05 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 30,000 | 24,300 | 46,438 | |
Apr 05 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 15.43 | 30,000 | 463,005 | 461,668 | 491.7 K to 461.7 K (-6.10 %) |
Apr 05 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 30,000 | 24,300 | 491,668 | 461.7 K to 491.7 K (+6.50 %) |
Mar 06 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | A | 13.50 | 105,255 | 1,420,943 | 105,255 | |
Mar 06 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Grant | A | 0.00 | 23,173 | 0 | 461,668 | 438.5 K to 461.7 K (+5.28 %) |
Feb 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 25,000 | 20,250 | 76,438 | |
Feb 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 13.36 | 25,000 | 333,875 | 438,495 | 463.5 K to 438.5 K (-5.39 %) |
Feb 07 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 25,000 | 20,250 | 463,495 | 438.5 K to 463.5 K (+5.70 %) |
Jan 04 2017 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Payment of Exercise | F | 14.95 | 4,819 | 72,044 | 438,495 | 443.3 K to 438.5 K (-1.09 %) |
Dec 20 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 7,052 | 5,712 | 101,438 | |
Dec 20 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 15.07 | 7,052 | 106,241 | 443,314 | 450.4 K to 443.3 K (-1.57 %) |
Dec 20 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 7,052 | 5,712 | 450,366 | 443.3 K to 450.4 K (+1.59 %) |
Dec 07 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 1,140 | 923 | 108,490 | |
Dec 07 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 15.00 | 1,140 | 17,100 | 443,314 | 444.5 K to 443.3 K (-0.26 %) |
Dec 07 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 1,140 | 923 | 444,454 | 443.3 K to 444.5 K (+0.26 %) |
Dec 05 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 1,000 | 810 | 109,630 | |
Dec 05 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | M | 0.81 | 19,925 | 16,139 | 110,630 | |
Dec 05 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 15.00 | 1,000 | 15,000 | 443,314 | 444.3 K to 443.3 K (-0.23 %) |
Dec 05 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 1,000 | 810 | 444,314 | 443.3 K to 444.3 K (+0.23 %) |
Dec 05 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Sell | S | 15.00 | 60,808 | 912,120 | 443,314 | 504.1 K to 443.3 K (-12.06 %) |
Dec 05 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Buy | M | 0.81 | 19,925 | 16,139 | 504,122 | 484.2 K to 504.1 K (+4.12 %) |
Mar 08 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | A | 10.21 | 128,959 | 1,316,671 | 128,959 | |
Mar 08 2016 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Grant | A | 0.00 | 30,950 | 0 | 484,197 | 453.2 K to 484.2 K (+6.83 %) |
Jun 23 2015 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Option Exercise | A | 14.12 | 41,931 | 592,066 | 41,931 | |
Jun 23 2015 | OXFD | Oxford Immunotec G ... | Wrighton-Smith Peter | Chief Executive Off ... | Grant | A | 0.00 | 22,066 | 0 | 453,247 | 431.2 K to 453.2 K (+5.12 %) |
Page: 1